General MedicationsTOPICALStandard
FLUOCINONIDE
FLUOCINONIDE
Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FLUOCINONIDE is listed in Drugs@FDA under application 216389 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient FLUOCINONIDE Form and strength SOLUTION;TOPICAL - 0.05% Sponsor QUAGEN Submission history Latest submission status date: 2025-02-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview FLUOCINONIDE is listed in Drugs@FDA under application 216389 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUOCINONIDE Form and strength SOLUTION;TOPICAL - 0.05% Sponsor QUAGEN Submission history Latest submission status date: 2025-02-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.